Dr. Bruce J. Tromberg Sworn in as New Lead of National Institutes of Health Bioengineering Agency

National Institutes of Health (NIH) Director Francis Collins recently swore in Dr. Bruce J. Tromberg to lead the National Institute of Biomedical Imaging and Bioengineering (NIBIB), the agency of the NIH focused on bioengineering.  Dr. Collins praised Dr. Tromberg’s new appointment, stating “Bruce brings substantial experience in biophotonics, and demonstrated his commitment to state-of-the-art imaging and bioengineering technologies through his research and leadership on numerous advisory committees, including the NIBIB National Advisory Council.”

Dr. Tromberg has a strong background in biophotonics and biomedical optics research, a field that uses light to image and conduct therapy at the molecular, cellular and tissue levels. He specializes in new technology development as well as the “bench to bedside” clinical translation, validation and commercialization of promising methods designed to improve human health. In this capacity, Dr Tromberg also spent 20 years as the principal investigator for the NIH National Biomedical Technology Resource Center Laser Microbeam and Medical Program (LAMMP). He now comes to the NIBIB after serving as professor in both the Departments of Biomedical Engineering and Surgery at the University of California, Irvine (UCI).

In his role as Director, Dr. Tromberg will be responsible for NIBIB’s annual budget, which totals roughly $378 million. He will also oversee a staff around 230 employees responsible for the research and development of new biomedical imaging and bioengineering technologies.

For more information on the work of the NIBIB, click here: https://www.nibib.nih.gov/